In this short and creative video, learn how to make a beautiful bracelet using the 3-wire braid technique. This DIY tutorial ...

PASADENA, Calif., July 08, 2025 -- (BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has dosed the first subject in the YOSEMITE Phase 3 clinical trial of ...

Investing.com -- Viatris Inc. (NASDAQ: VTRS) stock fell 3.6% after the company announced that its Phase 3 study of MR-139 for blepharitis did not meet its primary endpoint. The randomized, double ...

Pelage’s PP405, a first-in-class regenerative treatment, reactivates dormant stem cells to regrow hair. Phase 2a shows early, significant results.

Abivax Announces Positive Phase 3 Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod, its First-in-Class Oral miR-124 Enhancer, in Moderate to Severely Active Ulcerative Colitis ...

From 2017 to 2022, the number of women in trades rose from about 241,000 to nearly 354,000. That’s an increase of about 47%. Even so, women still constitute just 5.3% of welders in the United ...

Phase 3 OASISplus data demonstrating benefit of donidalorsen for HAE patients who switched from other prophylactics published in JACI In Practice Provided by Business Wire Jul 21, 2025, 4:00:00 AM ...

Ultragenyx is developing setrusumab in pediatric and young adult patients across OI sub-types I, III and IV with two late-stage studies: the pivotal Phase 2/3 Orbit study and Phase 3 Cosmic study.

MAIA Biotechnology Announces First Patient Dosed in Expansion of Phase 2 Trial for Ateganosine in Advanced Non-Small Cell Lung CancerCHICAGO-- (BUSINESS WIRE)-- MAIA Biotechnology, Inc. (NYSE ...

Phase 3 VERONA study of venetoclax with azacitidine to assess change in complete remission and overall survival in treatment-naïve higher-risk myelodysplastic syndromes.